Executive record

Andrew D’Silva

Most recent record: OptimizeRx Corporation CFO transition: Andrew D’Silva to succeed Edward Stelmakh (named as the incoming officer), effective January 1, 2027. See OptimizeRx Corporation.

1 verified record

2026-08-12 · Transition

OptimizeRx Corporation CFO transition: Andrew D’Silva to succeed Edward Stelmakh

This page lists only verified filing records that name Andrew D’Silva; it is not a career history. Corrections: the corrections page.